{"id":"W4401285068","doi":"10.1016/j.jcrc.2024.154892","title":"Antisense therapy to block the Kallikrein-kinin pathway in COVID-19: The ASKCOV randomized controlled trial","year":2024,"lang":"en","type":"article","venue":"Journal of Critical Care","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"Ionis Pharmaceuticals","keywords":"Medicine; Kallikrein; Coronavirus disease 2019 (COVID-19); Randomized controlled trial; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Internal medicine; Pharmacology; Virology; Biology; Biochemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008880533,0.0008836447,0.001940816,0.0002803548,0.0002271204,0.0007275562,0.0004251968,0.001006333,0.00566209],"category_scores_gemma":[0.001312665,0.0002499772,0.001228306,0.0003218582,0.0005017498,0.0004169102,0.0002336991,0.001079973,0.0004604136],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004784676,"about_ca_system_score_gemma":0.0008429487,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000816814,"about_ca_topic_score_gemma":0.001609789,"domain_scores_codex":[0.9996137,0.0001933524,0.0000396975,0.00006751401,0.00003724661,0.00004847919],"domain_scores_gemma":[0.9995944,0.000122591,0.0001211102,0.00002260181,0.00003534686,0.0001039329],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9757023,0.001464628,0.000959861,0.002298358,0.001267096,0.00004224953,0.00002114056,0.000183924,0.001862368,0.0002337166,0.0008753476,0.015089],"study_design_scores_gemma":[0.9830657,0.0131902,0.00156674,0.000100998,0.0006685113,0.00002542679,0.00001418542,0.0001771499,0.0002391148,0.00009694466,0.0008485322,0.000006506692],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.950596,0.03550857,0.0009943038,0.001671784,0.001291484,0.003727456,0.002391411,0.0001152874,0.0037036],"genre_scores_gemma":[0.9777015,0.01020955,0.001495049,0.001486107,0.00053543,0.003849131,0.001595277,0.00001550537,0.003112421],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00566209,"threshold_uncertainty_score":0.01894158,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03100094791928161,"score_gpt":0.365495768195039,"score_spread":0.3344948202757574,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}